UBS Group AG - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$125,995,000
+215.5%
833,464
+204.2%
0.06%
+243.8%
Q2 2022$39,929,000
+794.9%
274,026
+628.2%
0.02%
+1500.0%
Q1 2022$4,462,000
+175.6%
37,629
+220.4%
0.00%
Q4 2021$1,619,000
+93.0%
11,746
+94.3%
0.00%
Q3 2021$839,000
+90.2%
6,045
+33.2%
0.00%
Q2 2021$441,000
-83.6%
4,539
-88.5%
0.00%
-100.0%
Q1 2021$2,690,000
-13.9%
39,360
+8.0%
0.00%0.0%
Q4 2020$3,125,000
+218.2%
36,460
+141.4%
0.00%
Q3 2020$982,000
+591.5%
15,103
+677.3%
0.00%
Q2 2020$142,000
+264.1%
1,943
+69.3%
0.00%
Q1 2020$39,000
-27.8%
1,148
+16.7%
0.00%
Q4 2019$54,000
-98.7%
984
-99.0%
0.00%
-100.0%
Q3 2019$4,275,000
+1315.6%
102,479
+1384.6%
0.00%
Q2 2019$302,000
+40.5%
6,903
+65.3%
0.00%
Q1 2019$215,000
-54.2%
4,177
-67.1%
0.00%
Q4 2018$469,000
-11.0%
12,678
-9.6%
0.00%
Q3 2018$527,000
+296.2%
14,021
+317.3%
0.00%
Q2 2018$133,000
+121.7%
3,360
+45.2%
0.00%
Q1 2018$60,000
-13.0%
2,314
-9.6%
0.00%
Q4 2017$69,000
+392.9%
2,559
+593.5%
0.00%
Q3 2017$14,0003690.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders